Related Experiment Video
Updated: Feb 22, 2026

11:42
High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
Published on: December 28, 2015
31.9K
Human Cells as Platform to Produce Gamma-Carboxylated Proteins
Aline de Sousa Bomfim1,2, Marcela Cristina Corrêa de Freitas3, Dimas Tadeu Covas3,4
1Center for Cell-based Therapy CTC, Ribeirão Preto Medical School, University of São Paulo, Av. Tenente Catão Roxo 2501, Monte Alegre, 14051-140, Ribeirão Preto, SP, Brazil. alinesb@fcfrp.usp.br.
Methods in Molecular Biology (Clifton, N.J.)
|September 19, 2017
Summary
This study details methods for generating human cell lines to produce vitamin K-dependent gamma-carboxylated proteins, such as coagulation factors VII and IX, for therapeutic applications.
Area of Science:
- Biochemistry
- Molecular Biology
- Biotechnology
Background:
- Gamma-carboxylated proteins, essential for biological functions, require vitamin K for synthesis.
- Key examples include coagulation factors (VII, IX, X, prothrombin) and regulatory proteins (C, S, Z).
- Posttranslational modifications like gamma-carboxylation necessitate production in mammalian cell lines.
Purpose of the Study:
- To present methods for developing human cell lines as a production platform for gamma-carboxylated proteins.
- To focus on generating cell lines for producing coagulation factors VII and IX.
- To outline protocols for cell line modification and vitamin K adaptation.
Main Methods:
- Cell line engineering to enable gamma-carboxylation.
- Optimization of culture conditions for vitamin K-dependent protein production.
- Establishment of protocols for generating and adapting human cell lines.
Main Results:
- Demonstrated successful generation of human cell lines capable of producing gamma-carboxylated proteins.
- Provided detailed protocols for cell line modification and vitamin K adaptation.
- Established a viable platform for the biosynthesis of critical coagulation factors.
Conclusions:
- Human cell lines offer a promising alternative for producing complex gamma-carboxylated proteins.
- The presented methods facilitate the development of cell-based manufacturing for therapeutic proteins.
- This approach supports the efficient production of vital vitamin K-dependent factors.
Keywords:
Coagulation factorsGamma-carboxylated proteinsHuman cell linesRecombinant proteinsVitamin K cycle
